Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')

被引：26
|
作者：
Cohen, RS
Cocores, J
机构：
[1] FAIRLEIGH DICKINSON UNIV,MADISON,NJ
[2] FAMILY COUNSELING CTR,MORRISTOWN,NJ
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1997年 / 21卷 / 04期
关键词：
case report; Ecstasy; 3,4-methylenedioxymethamphetamine; MDMA; serotonin; side-effects;
D O I：
10.1016/S0278-5846(97)00045-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1. The recurring side-effects associated with MDMA consumption are reviewed. 2. The recreational use of ''Ecstasy'' has been implicated in the onset of various psychological, neurological, and organic complications. A table has been employed to depict the deleterious reactions that have occurred following MDMA ingestion. 3. An original case report is presented in which an individual developed perpetual neuropsychiatric symptomatology after having consumed MDMA. This case indicates that MDMA may induce long lasting effects, even after one exposure.
引用
收藏
页码：727 / 734
页数：8
相关论文
共 50 条
  • [1] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [2] Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion
    Hartung, TK
    Schofield, E
    Short, AI
    Parr, MJA
    Henry, JA
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2002, 95 (07) : 431 - 437
  • [3] The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
    Campbell, Garland A.
    Rosner, Mitchell H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1852 - 1860
  • [4] NEUROCHEMISTRY AND NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)
    MCKENNA, DJ
    PEROUTKA, SJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) : 14 - 22
  • [5] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    [J]. DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [6] The cardiovascular effects of ecstasy (3,4-methylenedioxymethamphetamine, MDMA)
    Lester, SJ
    Baggott, MJ
    Viloria, EM
    Welm, S
    Schiller, NB
    Mendelson, J
    Jones, RT
    Foster, E
    [J]. CIRCULATION, 1999, 100 (18) : 575 - 575
  • [7] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
    Montgomery, H
    Myerson, S
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
  • [8] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    [J]. JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [9] False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate
    Kaplan, Yusuf Cem
    Erol, Almila
    Karadas, Baris
    [J]. THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 493 - 495
  • [10] Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment
    Bhattachary, S
    Powell, JH
    [J]. PSYCHOLOGICAL MEDICINE, 2001, 31 (04) : 647 - 658
12345